Clinical Trials

Showing trials with last updates posted in 2023.

NCT04072445 | COMPLETED | PHASE2
28 participants

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2023-08-09
Start Date:
2019-10-18
Completion:
2021-08-13
Conditions
  • Advanced Bile Duct Carcinoma
  • Advanced Gallbladder Carcinoma
  • Refractory Bile Duct Carcinoma
  • Refractory Gallbladder Carcinoma
  • Stage III Distal Bile Duct Cancer AJCC v8
  • Stage III Gallbladder Cancer AJCC v8
  • Stage III Intrahepatic Bile Duct Cancer AJCC v8
  • Stage IIIA Distal Bile Duct Cancer AJCC v8
  • Stage IIIA Gallbladder Cancer AJCC v8
  • Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8
  • Stage IIIB Distal Bile Duct Cancer AJCC v8
  • Stage IIIB Gallbladder Cancer AJCC v8
  • Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8
  • Stage IV Distal Bile Duct Cancer AJCC v8
  • Stage IV Gallbladder Cancer AJCC v8
  • Stage IV Intrahepatic Bile Duct Cancer AJCC v8
  • Stage IVA Gallbladder Cancer AJCC v8
  • Stage IVB Gallbladder Cancer AJCC v8
Interventions
  • DRUG
NCT05982587 | UNKNOWN
360 participants

PCSP Implementation Study

Study Type:
OBSERVATIONAL
Last Updated:
2023-08-08
Start Date:
2023-08-01
Completion:
2024-08-31
Conditions
  • Survivorship
  • Late Effect
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page